Skip to content

The effect of intravenous anesthesia with fospropofol on postoperative recovery quality in patients undergoing elective abdominal surgery

The effect of intravenous anesthesia with fospropofol on postoperative recovery quality in patients undergoing elective abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103946
Enrollment
Unknown
Registered
2025-06-09
Start date
2025-06-20
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative recovery quality

Interventions

Control group (Group C):Intravenous injection of propofol
Experimental group (F group):Intravenous injection of fospropofol

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age range: 18-75 years old, gender not limited; (2) American Society of Anesthesiologists (ASA): Grades I-III; (3) Body Mass Index (BMI): 18.5-30 kg/m2; (4) Selective abdominal surgery is required under general anesthesia, with an estimated surgery time of 1-3 hours; (5) I voluntarily participated and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with contraindications to general anesthesia or a history of anesthesia accidents; (2) Patients with combined traumatic brain injury, intracranial hypertension, stroke, unstable angina, and myocardial infarction; (3) Respiratory insufficiency, obstructive pulmonary disease, presence of difficult airways, or difficulty in endotracheal intubation (modified Mahalanobis score III or IV) (4) Uncontrolled diabetes or hypertension; (5) History of drug use, alcohol abuse, or drug dependence; (6) Abuse or long-term use of anesthetics, sedatives, and analgesics; (7) Individuals who are known or suspected to be allergic or contraindicated to the various components of the investigational drug or the standardized use of drugs specified in the protocol (such as sufentanil citrate injection, propofol medium/long-chain fat emulsion, remifentanil hydrochloride injection, and propofol disodium injection); (8) Individuals with a history of mental illness; (9) Individuals who have participated in any drug clinical trials within the past month prior to screening; (10) The researchers believe that there are any other factors that are not suitable for participants in this experiment.

Design outcomes

Primary

MeasureTime frame
Recovery quality within 24 hours after surgery;

Secondary

MeasureTime frame
Recovery quality within 48 hours after surgery;Recovery quality within 72 hours after surgery;Quality evaluation of anesthesia recovery in PACU;Changes in hemodynamic indicators;postoperative side reactions;

Countries

China

Contacts

Public ContactLiwei Wang

Xuzhou Central Hospital

qiyu1987xiaobao@163.com+86 177 1298 8986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026